The latest price target for Xylem (NYSE:XYL) was reported by UBS on August 13, 2024. The analyst firm set a price target for $165.00 expecting XYL to rise to within 12 months (a possible 20.51% upside). 30 analyst firms have reported ratings in the last year.

The latest analyst rating for Xylem (NYSE:XYL) was provided by UBS, and Xylem initiated their buy rating.

The last upgrade for Xylem Inc happened on November 21, 2023 when Deutsche Bank raised their price target to $120. Deutsche Bank previously had a hold for Xylem Inc.

The last downgrade for Xylem Inc happened on January 4, 2023 when Raymond James changed their price target from N/A to N/A for Xylem Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Xylem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Xylem was filed on August 13, 2024 so you should expect the next rating to be made available sometime around August 13, 2025.

While ratings are subjective and will change, the latest Xylem (XYL) rating was a initiated with a price target of $0.00 to $165.00. The current price Xylem (XYL) is trading at is $136.92, which is within the analyst’s predicted range.